Table 3 a Complications after PreserfloTM Microshunt.
Procedures | Eyes (%) |
|---|---|
Early (≤1 month) | |
Device exposure | 1 (1%) |
Late (>1 months) | |
Anterior Uveitis | 2 (2%) |
Peripheral corneal oedema | 1 (1%) |
Iris incarceration | 1 (1%) |
Macular oedema secondary to CRVO | 1 (1%) |
b. Other procedures after PreserfloTM MicroShunt | |
Needle revision | 12 (12%) |
5-FU deposit | 5 (5%) |
Surgical revision for encapsulation | 4 (4%) |
Surgical revision for exposure | 1 (1%) |
Device removal | 1 (1%) |
